軟骨修復/軟骨再生の世界市場予測(〜2025):治療法別(細胞ベースタイプ(軟骨細胞移植、成長因子)、非細胞(組織足場))、用途別(硝子)、エンドユーザー別(ASC、クリニック)、部位別(膝)

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:BT 4781)
◆英語タイトル:Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Cell based Type (Chondrocyte Transplantation, Growth Factor), Non-Cell (Tissue Scaffolds)), Application (Hyaline), End User (ASCs, Clinic), Site (Knee) - Global Forecast to 2025
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:BT 4781
◆発行日:2020年10月20日
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆ページ数:151
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[軟骨修復/軟骨再生の世界市場予測(〜2025):治療法別(細胞ベースタイプ(軟骨細胞移植、成長因子)、非細胞(組織足場))、用途別(硝子)、エンドユーザー別(ASC、クリニック)、部位別(膝)]についてメールでお問い合わせはこちら
Marketsandmarkets社は軟骨修復/軟骨再生の世界市場が2020年787百万ドルから2025年1603百万ドルまで、年平均15.3%成長すると展望しています。本調査レポートでは、軟骨修復/軟骨再生の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、治療法別(セルベース、非セルベース)分析、部位別(膝、ヒップ、足首、足、その他)分析、用途別(硝子軟骨、線維軟骨)分析、エンドユーザー別(病院、外来手術センター・クリニック)分析、地域別分析、競争状況、企業情報など、以下の構成でお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・軟骨修復/軟骨再生の世界市場規模:治療法別(セルベース、非セルベース)
・軟骨修復/軟骨再生の世界市場規模:部位別(膝、ヒップ、足首、足、その他)
・軟骨修復/軟骨再生の世界市場規模:用途別(硝子軟骨、線維軟骨)
・軟骨修復/軟骨再生の世界市場規模:エンドユーザー別(病院、外来手術センター・クリニック)
・軟骨修復/軟骨再生の世界市場規模:地域別
・競争状況
・企業情報
*** レポート概要(サマリー)***

“The global cartilage repair and regeneration market is projected to reach USD 1,603 million by 2025 from USD 787 million in 2020, at a CAGR of 15.3% during the forecast period. The growth of this market is primarily driven by the increasing incidence of osteoarthritis and increasing funding and investments for research in this field.”

“By cell-based treatment modality, the chondrocyte transplantation segment accounted for the largest share of the cartilage repair and regeneration market”
Based on the treatment modality, the cartilage repair and regeneration market is segmented into cell-based and non-cell-based approaches. The cell-based segment is further divided into chondrocyte transplantation, growth factors, and stem cells. The chondrocyte transplantation segment accounted for the largest share of this market in 2019, owing to greater longevity and utility for larger lesions.

“By application site segment, the knee segment accounted for the fastest growing segment of the cartilage repair and regeneration market”
Based on the application site, the cartilage repair and regeneration market is segmented into knee, hip, ankle and foot, and other application sites (nose and shoulder). The knee segment is estimated to be the fastest growing application site segment of the global cartilage repair and regeneration market. This can be attributed to the growing number of knee arthroscopy procedures and the increasing incidence of knee osteoarthritis.

“Asia Pacific: The fastest-growing region in the cartilage repair and regeneration market.”
The Asia Pacific region is estimated to grow at the highest CAGR in the cartilage repair and regeneration market during the forecast period, this is mainly due to the rising geriatric population and the subsequent increase in the incidence of various disorders and injuries. Recent developments in tissue engineering and stem cell therapy will further fuel market growth.

“North America: the largest share of the cartilage repair and regeneration market”
North America accounted for the largest share of the global market, followed by Europe. The large share of the North American region can be attributed to the high burden of osteoarthritis, increasing prevalence of sports injuries, and increasing research investments in the US and Canada.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Respondent– Supply Side- 80%, Demand Side-20%
• By Designation— CXOs – 20%, Executives – 25%, Mangers – 55%
• By Region— North America – 50%, Europe – 20%, APAC – 20%, RoW- 10%

The cartilage repair and regeneration market is dominated by a few globally established players such as Arthrex, Inc. (US), Smith & Nephew plc (UK), DePuy Synthes (US), Stryker Corporation (US), CONMED Corporation (US), Zimmer Biomet Holdings, Inc. (US), RTI Surgical, Inc. (US), B. Braun Melsungen AG (Germany), Vericel Corporation (US), Anika Therapeutics (US), Geistlich Pharma AG (Switzerland), Regrow Biosciences (India), MEDIPOST Co., Ltd (South Korea), AlloSource (US), BioTissue SA (Switzerland), and Orthocell (Australia).

Research Coverage:
The report segments the cartilage repair and regeneration market based on region (Asia Pacific, Europe, North America, and RoW), Treatment Modality (cell-based and non-cell-based approaches), Application (hyaline cartilage and fibrocartilage), End User (hospitals and ambulatory surgery centers & clinics) and Application Site (knee, hip, ankle and foot, nose, and shoulder). The report also provides a comprehensive review of market drivers, restraints, opportunities, challenges and trends in the cartilage repair and regeneration market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the cartilage repair and regeneration market and provides them information on key market drivers, restraints, challenges, and opportunities.

*** レポート目次(コンテンツ)***

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 27
TABLE 1 INCLUSIONS & EXCLUSIONS 27
1.3 MARKET SCOPE 27
FIGURE 1 MARKETS COVERED 27
1.3.1 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 30
2.1.2 PRIMARY DATA 31
FIGURE 2 BREAKDOWN OF PRIMARIES: CARTILAGE REPAIR AND REGENERATION MARKET 31
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION 32
2.1.3.1 Data Triangulation 32
FIGURE 3 DATA TRIANGULATION METHODOLOGY 32
2.2 MARKET ESTIMATION METHODOLOGY 33
FIGURE 4 MARKET SIZE ESTIMATION APPROACH 1: COMPANY REVENUE ANALYSIS-BASED ESTIMATION 33
FIGURE 5 MARKET SIZE ESTIMATION APPROACH 2: TOP-DOWN APPROACH 34
FIGURE 6 CARTILAGE REPAIR AND REGENERATION MARKET SIZE (USD MILLION) 34
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 35
FIGURE 7 SEGMENTAL GROWTH RATE OF COMPANIES (2015−2019) 35
FIGURE 8 FINAL CAGR PROJECTIONS (2020−2025) 36
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES 36
2.4 INSIGHTS FROM PRIMARIES 37
FIGURE 10 MARKET VALIDATION FROM PRIMARY EXPERTS 37
2.5 RESEARCH ASSUMPTIONS 37
2.6 RISK ASSESSMENT 38
TABLE 2 RISK ASSESSMENT 38

3 EXECUTIVE SUMMARY 39
FIGURE 11 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY 39
FIGURE 12 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2020—2025 40
FIGURE 13 CARTILAGE REPAIR AND REGENERATION MARKET SHARE, BY END USER, 2019 40
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CARTILAGE REPAIR AND
REGENERATION MARKET 41
4 PREMIUM INSIGHTS 42
4.1 CARTILAGE REPAIR AND REGENERATION MARKET OVERVIEW 42
FIGURE 15 RISING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH 42
4.2 ASIA PACIFIC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY AND COUNTRY (2019) 43
FIGURE 16 CELL-BASED SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE
ASIA PACIFIC MARKET IN 2019 43
4.3 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES,
BY TYPE (2020–2025) 44
FIGURE 17 CHONDROCYTE TRANSPLANTATION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD 44
4.4 CARTILAGE REPAIR AND REGENERATION MARKET SHARE, BY APPLICATION,
2020 VS. 2025 44
FIGURE 18 HYALINE CARTILAGE IS THE LARGEST APPLICATION SEGMENT OF THE CARTILAGE REPAIR AND REGENERATION MARKET 44
4.5 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE,
2020 VS. 2025 (USD MILLION) 45
FIGURE 19 THE KNEE SEGMENT WILL CONTINUE TO DOMINATE THE CARTILAGE REPAIR AND REGENERATION MARKET IN 2025 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 20 CARTILAGE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 MARKET DRIVERS 47
5.2.1.1 Increasing incidence of osteoarthritis 47
5.2.1.2 Increasing research funding and investments 47
5.2.2 RESTRAINTS 47
5.2.2.1 High cost of cartilage repair surgeries 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Technological advancements 47
5.2.4 CHALLENGES 48
5.2.4.1 Limitation of cartilage-based stem cell products 48

5.3 SUPPLY CHAIN ANALYSIS 48
FIGURE 21 SUPPLY CHAIN ANALYSIS OF THE CARTILAGE REPAIR AND
REGENERATION MARKET 49
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE CARTILAGE REPAIR AND REGENERATION MARKET 50
FIGURE 22 COVID-19 IMPACT ON THE CARTILAGE REPAIR AND REGENERATION MARKET 50
5.5 REGULATORY ASSESSMENT 51
5.5.1 INTRODUCTION 51
5.5.2 NORTH AMERICA 51
5.5.3 EUROPE 52
5.5.4 ASIA PACIFIC 52
5.6 PATENT ANALYSIS 53
5.6.1 DOCUMENT TYPE 53
TABLE 3 PATENTS FILED 53
FIGURE 23 PATENTS FILED (2016—2020) 54
FIGURE 24 PATENTS FILED BETWEEN 2016 AND AUGUST 2020 54
5.6.2 INSIGHTS 55
FIGURE 25 JURISDICTION ANALYSIS (2019) 55
5.6.3 TOP APPLICANTS (2019) 55
5.7 PIPELINE ANALYSIS 56
5.7.1 BASED ON THE PHASE OF CLINICAL TRIAL 56
FIGURE 26 MAJORITY OF CARTILAGE REPAIR CANDIDATE PRODUCTS ARE IN PHASE 3 56
5.8 TECHNOLOGY ANALYSIS 57
6 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY 59
6.1 INTRODUCTION 60
TABLE 4 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 60
6.2 CELL-BASED 60
TABLE 5 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 60
TABLE 6 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 7 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 8 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 9 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION) 62
6.2.1 CHONDROCYTE TRANSPLANTATION 62
6.2.1.1 Cost-effectiveness of chondrocyte transplantation to support market growth 62
TABLE 10 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION,
2018–2025 (USD MILLION) 62
TABLE 11 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 62
6.2.2 GROWTH FACTORS 63
6.2.2.1 Promising results associated with growth factors is the major factor driving the growth of this segment 63
TABLE 12 GROWTH FACTORS MARKET, BY REGION, 2018–2025 (USD MILLION) 63
TABLE 13 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 63
6.2.3 STEM CELLS 63
6.2.3.1 Advancements in stem cell-based tissue engineering will drive the growth of this segment 63
TABLE 14 STEM CELLS MARKET, BY REGION, 2018–2025 (USD MILLION) 64
TABLE 15 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 64
6.3 NON-CELL-BASED 64
TABLE 16 CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 64
TABLE 17 CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY REGION, 2018–2025 (USD MILLION) 65
TABLE 18 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 19 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 20 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION) 66
6.3.1 TISSUE SCAFFOLDS 66
6.3.1.1 Benefits of the one-step procedure likely to boost the market growth 66
TABLE 21 TISSUE SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION) 66
6.3.2 CELL-FREE COMPOSITES 67
6.3.2.1 Increasing research to support market growth 67
TABLE 22 CELL-FREE COMPOSITES MARKET, BY REGION, 2018–2025 (USD MILLION) 67
7 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE 68
7.1 INTRODUCTION 69
TABLE 23 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 69
7.2 KNEE 69
7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH 69
TABLE 24 CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY REGION, 2018–2025 (USD MILLION) 69
TABLE 25 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 26 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE,
BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 27 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE,
BY COUNTRY, 2018–2025 (USD MILLION) 70

7.3 HIP 71
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH 71
TABLE 28 CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY REGION, 2018–2025 (USD MILLION) 71
TABLE 29 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION) 71
TABLE 30 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP,
BY COUNTRY, 2018–2025 (USD MILLION) 72
TABLE 31 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP,
BY COUNTRY, 2018–2025 (USD MILLION) 72
7.4 ANKLE & FOOT 72
7.4.1 INCREASING SPORTS INJURIES IN THE ANKLE & FOOT ARE LIKELY TO DRIVE THE DEMAND FOR CARTILAGE REPAIR PROCEDURES 72
TABLE 32 CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT,
BY REGION, 2018–2025 (USD MILLION) 73
TABLE 33 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY COUNTRY, 2018–2025 (USD MILLION) 73
TABLE 34 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY COUNTRY, 2018–2025 (USD MILLION) 73
7.5 OTHER APPLICATION SITES 74
TABLE 35 CARTILAGE REPAIR AND REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2018–2025 (USD MILLION) 74
TABLE 36 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2018–2025 (USD MILLION) 74
8 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION 75
8.1 INTRODUCTION 76
TABLE 37 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
8.2 HYALINE CARTILAGE 76
8.2.1 HYALINE CARTILAGE SEGMENT HOLDS THE LARGER MARKET SHARE 76
TABLE 38 HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION) 76
TABLE 39 NORTH AMERICA: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 40 EUROPE: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 41 APAC: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 77
8.3 FIBROCARTILAGE 78
8.3.1 FIBROCARTILAGE PROVIDES SUPPORT AND RIGIDITY TO SURROUNDING STRUCTURES 78
TABLE 42 FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY REGION,
2018–2025 (USD MILLION) 78
TABLE 43 NORTH AMERICA: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 44 EUROPE: FIBROCARTILAGE REPAIR AND REGENERATION MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 45 APAC: FIBROCARTILAGE REPAIR AND REGENERATION MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 79
9 CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER 80
9.1 INTRODUCTION 81
TABLE 46 CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER,
2018–2025 (USD MILLION) 81
9.2 HOSPITALS 81
9.2.1 HOSPITALS ARE THE LARGEST & FASTEST-GROWING END USERS
OF THE MARKET 81
TABLE 47 CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS,
BY REGION, 2018–2025 (USD MILLION) 81
TABLE 48 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET
FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 49 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 50 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS,
BY COUNTRY, 2018–2025 (USD MILLION) 82
9.3 AMBULATORY SURGERY CENTERS & CLINICS 83
9.3.1 RISING PREFERENCE FOR PERFORMING SURGERIES IN ASCS IS SUPPORTING THE GROWTH OF THIS SEGMENT 83
TABLE 51 CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS,
BY REGION, 2018–2025 (USD MILLION) 83
TABLE 52 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 53 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 54 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 84
10 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION 85
10.1 INTRODUCTION 86
FIGURE 27 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION,
2020 VS. 2025 (USD MILLION) 86
TABLE 55 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION,
2018–2025 (USD MILLION) 86
10.2 NORTH AMERICA 87
FIGURE 28 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET SNAPSHOT 87
TABLE 56 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 57 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET,
BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 88
TABLE 58 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET
FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 88
TABLE 59 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 60 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET,
BY END USER, 2018–2025 (USD MILLION) 89
TABLE 61 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 89
TABLE 62 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET,
BY APPLICATION SITE, 2018–2025(USD MILLION) 90
10.2.1 US 90
10.2.1.1 Increasing incidence of obesity is the major factor supporting the market growth in the US 90
TABLE 63 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 90
TABLE 64 US: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 91
TABLE 65 US: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 91
TABLE 66 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER,
2018–2025 (USD MILLION) 91
TABLE 67 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 92
TABLE 68 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 92
10.2.2 CANADA 92
10.2.2.1 Increasing investments in regenerative medicine research to drive market growth 92
TABLE 69 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 93
TABLE 70 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 71 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 72 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 94
TABLE 73 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 94
TABLE 74 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 94
10.3 EUROPE 95
TABLE 75 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 95
TABLE 76 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 95
TABLE 77 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 95
TABLE 78 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 96
TABLE 79 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 96
TABLE 80 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 96
TABLE 81 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 97
10.3.1 GERMANY 97
10.3.1.1 Strong R&D base and focus on minimally invasive surgeries to support market growth 97
TABLE 82 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 97
TABLE 83 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 84 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 85 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 98
TABLE 86 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 99
TABLE 87 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET,
BY APPLICATION SITE, 2018–2025 (USD MILLION) 99
10.3.2 UK 99
10.3.2.1 Rising number of clinical trials in the UK to drive market growth 99
TABLE 88 UK: CARTILAGE REPAIR AND REGENERATION PRODUCTS UNDER CLINICAL TRIALS 100
TABLE 89 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 100
TABLE 90 UK: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 91 UK: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 101
TABLE 92 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER,
2018–2025 (USD MILLION) 101
TABLE 93 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 101
TABLE 94 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 102
10.3.3 FRANCE 102
10.3.3.1 Rising healthcare expenditure in the country to drive market growth 102
TABLE 95 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 102
TABLE 96 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 97 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 98 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 103
TABLE 99 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 104
TABLE 100 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 104
10.3.4 REST OF EUROPE 104
TABLE 101 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 105
TABLE 102 ROE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 103 ROE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 104 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 106
TABLE 105 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 106
TABLE 106 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 106
10.4 ASIA PACIFIC 107
FIGURE 29 ASIA PACIFIC: CARTILAGE REPAIR AND REGENERATION MARKET 107
TABLE 107 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 108 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 108
TABLE 109 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 108
TABLE 110 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 111 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 109
TABLE 112 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 109
TABLE 113 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 110
10.4.1 JAPAN 110
10.4.1.1 Rising geriatric population is the major factor supporting market growth in Japan 110
TABLE 114 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 110
TABLE 115 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 116 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 117 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 111
TABLE 118 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 112
TABLE 119 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 112
10.4.2 CHINA 112
10.4.2.1 China forms the fastest-growing market in the APAC 112
TABLE 120 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 113
TABLE 121 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 122 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 123 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 114
TABLE 124 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 114
TABLE 125 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 114
10.4.3 INDIA 115
10.4.3.1 Medical tourism will propel market growth in India 115
TABLE 126 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 115
TABLE 127 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 128 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 129 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 116
TABLE 130 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 116
TABLE 131 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 117
10.4.4 REST OF ASIA PACIFIC 117
TABLE 132 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 117
TABLE 133 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 134 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 135 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 118
TABLE 136 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 119
TABLE 137 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 119
10.5 REST OF THE WORLD 119
TABLE 138 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION) 119
TABLE 139 ROW: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 120
TABLE 140 ROW: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION) 120
TABLE 141 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION) 120
TABLE 142 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 121
TABLE 143 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION) 121
11 COMPETITIVE LANDSCAPE 122
11.1 INTRODUCTION 122
11.2 MARKET RANKING ANALYSIS 122
FIGURE 30 CARTILAGE REPAIR AND REGENERATION MARKET RANKING, 2019 122
11.2.1 MARKET REVENUE ANALYSIS (2015–2019) 123
FIGURE 31 REVENUE ANALYSIS OF MAJOR PLAYERS (2015−2019) 123
11.3 MARKET EVALUATION FRAMEWORK 123
TABLE 144 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH—THE MAJOR STRATEGY ADOPTED BY PLAYERS 123
11.4 COMPETITIVE SCENARIO 124
11.4.1 KEY PRODUCT LAUNCHES 124
11.4.2 KEY ACQUISITIONS 124
11.4.3 KEY COLLABORATIONS 124
11.4.4 KEY EXPANSIONS 124
11.5 COMPANY EVALUATION MATRIX 125
11.5.1 STARS 125
11.5.2 EMERGING LEADERS 125
11.5.3 PARTICIPANTS 125
11.5.4 PERVASIVE 125
FIGURE 32 CARTILAGE REPAIR AND REGENERATION MARKET:
COMPETITIVE EVALUATION MATRIX (2019) 126
12 COMPANY PROFILES 127
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
12.1 SMITH & NEPHEW PLC 127
FIGURE 33 SMITH & NEPHEW: COMPANY SNAPSHOT (2019) 127
12.2 DEPUY SYNTHES 129
FIGURE 34 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019) 129
12.3 ZIMMER BIOMET HOLDINGS, INC. 131
FIGURE 35 ZIMMER BIOMET: COMPANY SNAPSHOT (2019) 131
12.4 STRYKER CORPORATION 133
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2019) 133
12.5 VERICEL CORPORATION 135
FIGURE 37 VERICEL CORPORATION: COMPANY SNAPSHOT (2019) 135
12.6 B. BRAUN MELSUNGEN AG 136
FIGURE 38 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019) 136
12.7 ANIKA THERAPEUTICS 138
FIGURE 39 ANIKA THERAPEUTICS: COMPANY SNAPSHOT (2019) 138
12.8 RTI SURGICAL 140

12.9 CONMED CORPORATION 141
FIGURE 40 CONMED CORPORATION: COMPANY SNAPSHOT (2019) 141
12.10 ARTHREX, INC. 143
12.11 REGROW BIOSCIENCES 144
12.12 MEDIPOST 145
FIGURE 41 MEDIPOST: COMPANY SNAPSHOT (2019) 145
12.13 GEISTLICH PHARMA AG 147
12.14 ALLOSOURCE 148
12.15 ORTHOCELL LTD. 149
12.16 BIOTISSUE SA 150
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
13 APPENDIX 151
13.1 DISCUSSION GUIDE 151
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 154
13.3 AVAILABLE CUSTOMIZATIONS 156
13.4 RELATED REPORTS 156
13.5 AUTHOR DETAILS 157



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BT 4781 )"軟骨修復/軟骨再生の世界市場予測(〜2025):治療法別(細胞ベースタイプ(軟骨細胞移植、成長因子)、非細胞(組織足場))、用途別(硝子)、エンドユーザー別(ASC、クリニック)、部位別(膝)" (英文:Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Cell based Type (Chondrocyte Transplantation, Growth Factor), Non-Cell (Tissue Scaffolds)), Application (Hyaline), End User (ASCs, Clinic), Site (Knee) - Global Forecast to 2025)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。